Cargando…
Effects of lorcaserin on pre‐existing valvulopathy: A pooled analysis of phase 3 trials
OBJECTIVE: To evaluate the effects of lorcaserin in patients with pre‐existing Food and Drug Administration (FDA)‐defined valvulopathy. METHODS: This is a pooled, post hoc analysis of three Phase 3 studies. BLOOM and BLOSSOM patients were 18 to 65 years of age without diabetes and with a body mass i...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680283/ https://www.ncbi.nlm.nih.gov/pubmed/27888609 http://dx.doi.org/10.1002/oby.21695 |